Dana Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-46,749
| Closed | -$2.8M | – | 284 |
|
|
2018
Q2 | $2.8M | Sell |
46,749
-9,857
| -17% | -$590K | 0.12% | 125 |
|
|
2018
Q1 | $2.59M | Sell |
56,606
-798
| -1% | -$36.6K | 0.12% | 129 |
|
|
2017
Q4 | $2.29M | Sell |
57,404
-662
| -1% | -$26.4K | 0.1% | 162 |
|
|
2017
Q3 | $2.32M | Sell |
58,066
-101
| -0.2% | -$4.04K | 0.11% | 161 |
|
|
2017
Q2 | $2.51M | Sell |
58,167
-22,864
| -28% | -$985K | 0.12% | 142 |
|
|
2017
Q1 | $2.54M | Sell |
81,031
-7,047
| -8% | -$221K | 0.12% | 142 |
|
|
2016
Q4 | $2.22M | Sell |
88,078
-946
| -1% | -$23.9K | 0.1% | 169 |
|
|
2016
Q3 | $2.2M | Sell |
89,024
-15,233
| -15% | -$377K | 0.11% | 139 |
|
|
2016
Q2 | $2.12M | Buy |
104,257
+16,912
| +19% | +$345K | 0.09% | 160 |
|
|
2016
Q1 | $1.33M | Buy |
+87,345
| New | +$1.33M | 0.06% | 180 |
|